Immune-Mediated Low Platelet or Thrombocyte Count

Similar documents
Less stress for you and your pet

LYMPHOMA IN DOGS. Diagnosis/Initial evaluation. Treatment and Prognosis

Canine Lymphoma Frequently Asked Questions by Pet Owners

Adult Medical-Surgical Nursing H A E M A T O L O G Y M O D U L E : L E U K A E M I A 2

Seizures (Convulsions, Status Epilepticus) in Dogs

Multiple Myeloma. This reference summary will help you understand multiple myeloma and its treatment options.

INDICATIONS FOR BLOOD PRODUCT TRANSFUSIONS

Feline Lymphoma Chemotherapy and Chemotherapy Protocols

Acute myeloid leukemia (AML)

Acute Myeloid Leukemia

Diagnostics: Page 2 of 5

Understanding How Existing and Emerging MS Therapies Work

Blood & Marrow Transplant Glossary. Pediatric Blood and Marrow Transplant Program Patient Guide

1333 Plaza Blvd, Suite E, Central Point, OR *

Introduction. About 10,500 new cases of acute myelogenous leukemia are diagnosed each

The Anorexic Cat For this reason, any cat that stops eating for any reason is considered an emergency situation.

NORD Guides for Physicians #1. Physician s Guide to. Tyrosinemia. Type 1

Selective IgA deficiency (slgad)

SARCOIDOSIS. Signs and symptoms associated with specific organ involvement can include the following:

UW MEDICINE PATIENT EDUCATION. Xofigo Therapy. For metastatic prostate cancer. What is Xofigo? How does it work?

Canine Immune-Mediated Hemolytic Anemia

What You Need to know about Your Pet s Upcoming Dentistry and Periodontal Treatment

Leukaemia and lymphoma what s the difference?

Multiple Myeloma Understanding your diagnosis

ACUTE MYELOID LEUKEMIA (AML),

Estimated New Cases of Leukemia, Lymphoma, Myeloma 2014

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge.

School-age child 5-1 THE BLOOD

PERIPHERAL STEM CELL TRANSPLANT INTRODUCTION

An overview of CLL care and treatment. Dr Dean Smith Haematology Consultant City Hospital Nottingham

Aggressive lymphomas. Michael Crump Princess Margaret Hospital

Treatment of low-grade non-hodgkin lymphoma

37 2 Blood and the Lymphatic System Slide 1 of 34

VAD Chemotherapy Regimen for Multiple Myeloma Information for Patients

Introduction Hemophilia is a rare bleeding disorder in which the blood does not clot normally. About 1 in 10,000 people are born with hemophilia.

Chapter 3. Immunity and how vaccines work

1400 Telegraph Bloomfield Hills, MI Phone number/ fax Number CANCER TREATMENT

Dogs and cats with pancreatitis can have a wide variety of signs, which include, but are not limited to the following:

Hepatic Encephalopathy (Brain Disorder Secondary to Liver Disease) Basics

Canine Distemper Virus

Interpretation of Laboratory Values

INITIATING ORAL AUBAGIO (teriflunomide) THERAPY

Thymus Cancer. This reference summary will help you better understand what thymus cancer is and what treatment options are available.

Other treatments for chronic myeloid leukaemia

Hydroxyurea Treatment for Sickle Cell Disease

Other Causes of Fever

Bile Duct Diseases and Problems

Blood, Lymphatic and Immune Systems

Spinal Cord Diseases in Bernese Mountain Dogs

Feline Lower Urinary Tract Disease (FLUTD)

Heart transplantation

Other Noninfectious Diseases. Chapter 31 Lesson 3

Owner Manual. Diabetes in Dogs. Simplifying small animal diabetes

Gateway Health SM Non-Formulary Prior Authorization Criteria Intravenous Immune Globulin (IVIG)

Urinary Incontinence

Immune System Memory Game

Managing Lymphoma. Professor Clare Knottenbelt BVSc MSc DSAM MRCVS

Treating myeloma. Dr Rachel Hall Royal Bournemouth Hospital

Blood Transfusion. Red Blood Cells White Blood Cells Platelets

Severe rheumatoid arthritis (a disease that causes inflammation of the joints),where MabThera is given intravenously together with methotrexate.

Kidney or renal disease

Multiple Myeloma. Understanding your diagnosis

Transient Hypogammaglobulinemia of Infancy. Chapter 7

Feline Cystitis (Feline Lower Urinary Tract Disease)

CVP Chemotherapy Regimen for Lymphoma Information for Patients

VCA Animal Specialty Group 5610 Kearny Mesa Rd., Suite B San Diego, CA

10. T and B cells are types of a. endocrine cells. c. lymphocytes. b. platelets. d. complement cells.

Leukemias and Lymphomas: A primer

In non-hodgkin s lymphoma, MabThera is used to treat two types of the disease, both of which affect B-lymphocytes:

Vincristine by short infusion Doxorubicin by injection Cyclophosphamide by injection Rituximab by an infusion over between 60 minutes to a few hours

APPENDIX I-A: INFORMED CONSENT BB IND Protocol CDC IRB #4167

chronic leukemia lymphoma myeloma differentiated 14 September 1999 Pre- Transformed Ig Surface Surface Secreted Myeloma Major malignant counterpart

Sepsis Awareness Month

The Immune System: A Tutorial

Prostate Cancer. There is no known association with an enlarged prostate or benign prostatic hyperplasia (BPH).

Stepping toward a different treatment option LEARN WHAT ACTHAR CAN DO FOR YOU

TC: Docetaxel and Cyclophosphamide

Adjuvant Therapy for Breast Cancer: Questions and Answers

An Introduction to PROSTATE CANCER

MANAGING ANEMIA. When You Have Kidney Disease or Kidney Failure.

Zika Virus. Fred A. Lopez, MD, MACP Richard Vial Professor Department of Medicine Section of Infectious Diseases

INTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia

Mitoxantrone. For multiple sclerosis. InfoNEURO INFORMATION FOR PATIENTS. Montreal Neurological Hospital

What You Should Know About Lyme Disease and Other Tick-Borne Diseases. Sudbury Board of Health

COMMUNICABLE DISEASE

INTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia

Blood Transfusion. There are three types of blood cells: Red blood cells. White blood cells. Platelets.

Brain Cancer. This reference summary will help you understand how brain tumors are diagnosed and what options are available to treat them.

Making Sense of Blood Work in Greyhounds. By William E. Feeman III, DVM, C. Guillermo Couto, DVM, diplomate ACVIM, M. Cristina Iazbik, DVM

What Is. Norovirus? Learning how to control the spread of norovirus. Web Sites

GFR (Glomerular Filtration Rate) A Key to Understanding How Well Your Kidneys Are Working

GI Bleeding. Thomas S.Foster,Pharm.D. PHR 961 Integrated Therapeutics

Transcription:

rally is Customer Name, Street Address, City, State, Zip code Phone number, Alt. phone number, Fax number, e-mail address, web site Immune-Mediated Low Platelet or Thrombocyte Count (Thrombocytopenia) Basics OVERVIEW Platelets and thrombocytes are names for the normal cell fragments that originate in the bone marrow and travel in the blood as it circulates through the body; platelets act to plug tears in the blood vessels and to stop bleeding gene The range for normal platelet counts in dogs and cats 200,000/µl to 500,000/µl of blood (although reference ranges can vary in different medical laboratories) Thrombocytopenia is a low platelet count, indicating a small number of platelets are present in the circulating blood Primary immune-mediated thrombocytopenia is destruction of platelets by the immune system, with no identifiable cause Secondary immune-mediated low platelet count (thrombocytopenia) antibodies (proteins produced by the immune system in response to a specific antigen) are produced in response to certain triggers, such as infectious diseases, cancer, vaccinations or medications; the antibodies are directed against the platelets and result in premature destruction of the platelets, thus decreasing platelet numbers GENETICS Frequently recognized in particular dog breeds and is often familial (runs in certain families or lines of dogs), suggesting a strong genetic influence SIGNALMENT/DESCRIPTION OF PET Species Common in dogs Rare (or rarely diagnosed) in cats Breed or Familial Predilections Cocker spaniels, poodles, Old English sheepdogs, and Irish setters, but any breed can be affected

Mean Age and Range Mostly middle-aged dogs Dogs mean age, 5 years; reported age range is 4 months 15 years Cats mean age, 6 years; range, 8 months 12 years Predominant Sex Female dogs (spayed or intact) are more likely to have immune-mediated low platelet count (thrombocytopenia) than males SIGNS/OBSERVED CHANGES IN THE PET Dogs sudden (acute) onset of bleeding (known as hemorrhage ), bleeding primarily on visible areas of body (known as surface hemorrhage ); lack of appetite (known as anorexia ), sluggishness (lethargy), weakness Long-term (chronic) blood loss due to immune-mediated low platelet counts (thrombocytopenia) is very rare Cats sluggishness (lethargy), lack of appetite (anorexia), and bleeding, primarily on visible areas of body (surface hemorrhage) Some cases have no clinical signs and the low platelet counts have been found on routine health examinations or presurgical bloodwork Nose bleed (known as epistaxis ); bleeding from the moist tissues of the body (known as mucosal hemorrhages ) Small, pinpoint areas of bleeding (known as petechiae ); bruises or purplish patches, due to bleeding (known as ecchymoses ) in the moist tissues of the body or in the skin Bleeding in or around the eyes Black, tarry stools due to the presence of digested blood (known as melena ); bloody stools (known as hematochezia ); vomiting blood (known as hematemesis )Pale gums and moist tissues of the body (known as mucous membrane pallor ) due to blood loss, low red-blood cell counts (known as anemia ), or hemorrhagic shock (where the blood volume has decreased through bleeding to the point that circulation or flow of blood is unable to sustain the body) Nervous system signs (rare) due to bleeding into the central nervous system Fever and mildly enlarged lymph nodes (known as lymphadenomegaly ) are unusual Occasionally an enlarged spleen (known as splenomegaly ) may be detected on physical examination CAUSES Unknown RISK FACTORS May be preceded by a stressful event or vaccination (rarely reported) Treatment HEALTH CARE Uncomplicated cases with low bleeding risk and good owner compliance may be treated as outpatients Pets with severely low platelet counts have very high risk of bleeding and warrant strict refinement (such as cage rest) Intensive nursing care may be needed based on patient signs, such as moderate-to-severe bleeding; low blood volume (known as hypovolemia ); central nervous system signs Transfusion of platelet-containing products, such as fresh whole blood, platelet-rich plasma, or platelet concentrate in pets with severe bleeding Transfusion of packed red-blood cell or fresh whole blood to correct blood loss anemia Low blood volume (hypovolemia) can be managed by administration of crystalloids (fluids that contain electrolytes [chemical compounds, such as sodium, potassium, chloride] necessary for the body to function, crystalloids generally are similar to the fluid content [plasma] of the blood and move easily between the blood and body tissues, example is lactated Ringer's solution) Avoid use of injections into the muscle (known as intramuscular or IM injection) and under the skin (known as subcutaneous or SQ injections); apply pressure after injections into a vein (known as intravascular or IV injections)

ACTIVITY Pets with severely low platelet counts have very high risk of bleeding and warrant strict refinement (such as cage rest) Strict rest is important to minimize the risk of bleeding DIET Avoid hard foods SURGERY High risk of bleeding in dogs with severely low platelet counts (thrombocytopenia) Pet may require extensive transfusions before, during, and after surgery Surgical removal of the spleen (known as splenectomy ) is an option for cases that do not respond to medical treatment; discuss the risks and benefits of surgery with your pet's veterinarian Medications Medications presented in this section are intended to provide general information about possible treatment. The treatment for a particular condition may evolve as medical advances are made; therefore, the medications should not be considered as all inclusive Steroids prednisone or prednisolone or dexamethasone Antibiotics if infection or tick-borne disease is suspected Gastrointestinal protectants (such as sucralfate [medication that forms a protective barrier over a gastrointestinal ulcer} and or histamine (H2) blockers (such as famotidine) and/or proton pump inhibitors (such as omeprazole) to prevent or treat gastrointestinal ulcers Acute management in dogs vincristine is a chemotherapy drug; may be administered in combination with prednisone Vincristine or human immunoglobulins in combination with prednisone has led to a more rapid increase in platelet count Other immunosuppressive drugs (drugs that decrease the immune response) cyclosporine, azathioprine, leflunomide, danazol, chlorambucil (cats) Once the platelet count is in the normal range, the initial dose of prednisone will be tapered slowly over approximately 6 months, if no relapse occurs Follow-Up Care PATIENT MONITORING Check packed cell volume (PCV, a means of measuring the percentage volume of red-blood cells as compared to the fluid volume of blood) 2 3 times a day in pets with severe bleeding (risk of life-threatening gastrointestinal bleeding) Perform platelet counts daily until platelet counts are greater than 50,000/µL; then every few days, until platelet counts normalize Platelet counts should be performed every 1 3 weeks during the period of gradually tapering medications Complete blood count (CBC) and serum biochemistry profile every 2 4 weeks Bacterial culture of the urine and urinalysis every 4 6 weeks, due to risk of secondary infections PREVENTIONS AND AVOIDANCE Use vaccines judiciously role of vaccines in recurrence of immune-mediated thrombocytopenia is uncertain Minimize stress that may initiate recurrence POSSIBLE COMPLICATIONS Excessive bleeding can be fatal; sudden death may occur due to bleeding into the central nervous system or in the pericardial sac (the sac that surrounds the heart) Side effects of medications, such as gastrointestinal ulceration Medication-induced excessive levels of steroids in the body (known as iatrogenic hyperadrenocorticism or iatrogenic Cushing's syndrome ) Opportunistic infections (infection caused by a organism that usually does not cause disease, but is able to cause

disease because the pet's body and/or immune system has been weakened by some other disease process) Decreased production of blood cells and platelets by the bone marrow (known as bone marrow suppression ) EXPECTED COURSE AND PROGNOSIS Platelet counts usually will increase to greater than 50,000/µL after 5 7 days of starting treatment Vincristine or human immunoglobulins in combination with prednisone has led to a more rapid increase in platelet count Few dogs never achieve normal platelet counts Failure to respond to treatment should prompt reconsideration of the diagnosis Five of 19 dogs (26%) relapsed after 19 286 days (median time to relapse, 66 days); causes for relapse were dose reduction of prednisone, lack of owner follow through with treatment plan, or both If relapses occur a second immunosuppressive drug should be added, a more gradual tapering is advised, leaving the animal on an alternating daily regimen possibly for the rest of its life 29 of 30 dogs (97%) survived during the first 14 days; prognosis seems favourable with intensive therapy, including blood- or platelet-containing products or both, if needed Mortality rate in cats is 15% Key Points Platelets and thrombocytes are names for the normal cell fragments that originate in the bone marrow and travel in the blood as it circulates through the body; platelets act to plug tears in the blood vessels and to stop bleeding Thrombocytopenia is a low platelet count, indicating a small number of platelets are present in the circulating blood Primary immune-mediated thrombocytopenia is destruction of platelets by the immune system, with no identifiable cause Strict rest (such as cage rest) is important to minimize risk of bleeding The owner's willingness and ability to follow directions for the care of the pet are vital Risk of recurrence and complications should be understood

Enter notes here Blackwell's Five-Minute Veterinary Consult: Canine and Feline, Fifth Edition, Larry P. Tilley and Francis W.K. Smith, Jr. 2011 John Wiley & Sons, Inc.